ProShares - Ultra Nasdaq Biotechnology (BIB) Dividend Yield, History & Forecast

ProShares - Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund (ETF) listed on the NASDAQ Global Market. The most recent ex-dividend date was March 25, 2026, with payment scheduled for March 31, 2026. market capitalization is approximately $74M.

Loading quote...

Frequently Asked Questions about ProShares - Ultra Nasdaq Biotechnology (BIB)

When does ProShares - Ultra Nasdaq Biotechnology pay its next dividend?
The most recent ex-dividend date was March 25, 2026. The next scheduled dividend payment date is March 31, 2026.
Is ProShares - Ultra Nasdaq Biotechnology a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is ProShares - Ultra Nasdaq Biotechnology in?
ProShares - Ultra Nasdaq Biotechnology (BIB) operates in the Financial Services sector, specifically the Asset Management - Leveraged industry.